Safety and immunogenicity of AS03 B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study

Safety and immunogenicity of AS03 B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study

Show other versions (1)

Objectives: To compare the safety, reactogenicity, and immunogenicity of an adjuvanted split virion H1N1 vaccine and a non-adjuvanted whole virion vaccine used in the pandemic immunisation programme in the United Kingdom. Design: Open label, randomised, parallel group, phase II study. Setting: Five...

Full description

Bibliographic Details
Main Authors: Waddington, C, Walker, W, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, P, Allen, R, Okike, I, Ladhani, S, Sheasby, E, Hoschler, K, Andrews, N, Waight, P, Collinson, A, Heath, P, Finn, A, Faust, SN, Snape, MD, Miller, E, Pollard, A
Format: Journal article
Language:English
Published: 2010

Similar Items